Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: Joe NYC who wrote (1387)	9/27/2008 10:50:14 AM
From: LindyBill	Respond to of 39297

Another comment today from Davis: ..........I won't pretend to have the final answers on K2. That's why we've posed this as a preliminary issue, one to consider but not a "requirement" for success. Several issues to bear in mind: 1) MK-4 is likely the form responsible for the benefits observed in the two Dutch studies, since the principal sources were cheese, meats, and dairy. 2) MK-7 is the form responsible for bone health in the Japanese experience, though at far higher doses. We are all struggling to sort this information out. Nobody knows what the final answer is. While manufacturers often pretend to know the answer, making extravagant claims, it is not backed up by real data. Nonetheless, I remain excited about the possibilities for K2. But we really, really need more information.